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Abnormalities of tau protein are central to the pathogenesis of Progressive Supranuclear Palsy 
whilst haplotype variation of the tau gene MAPT influences the risk of Parkinson's disease and 
Parkinson’s disease dementia. We assessed whether regional MAPT expression might be associated 
with selective vulnerability of global brain networks to neurodegenerative pathology. Using task-
free functional magnetic resonance imaging in Progressive Supranuclear Palsy, Parkinson's disease 
and healthy subjects (n=128) we examined functional brain networks and measured the connection 
strength between 471 grey matter regions. We obtained MAPT and SNCA microarray expression 
data in healthy subjects from the Allen brain atlas. Regional connectivity varied according to the 
normal expression of MAPT. The regional expression of MAPT correlated with the proportionate 
loss of regional connectivity in Parkinson’s disease. Executive cognition was impaired in proportion 
to the loss of hub connectivity. These effects were not seen with SNCA, suggesting that alpha-
synuclein pathology is not mediated through global network properties. The results establish a link 
between regional MAPT expression and selective vulnerability of functional brain networks to 
neurodegeneration. 
 
Keywords: Tau, Progressive Supranuclear Palsy, Parkinson’s disease, Gene expression, Functional 
connectivity, Brain imaging 
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Several neurodegenerative diseases are associated with the hyperphosphorylation, misfolding and 
aggregation of the microtubule associated protein tau, including Progressive Supranuclear Palsy 
(PSP), Frontotemporal dementia and Alzheimer's disease. Genetic variations in the tau gene MAPT 
also increase the risk of PSP, Frontotemporal dementia, Parkinson's disease (PD) (Martin et al., 
2001; Satake et al., 2009; Simón-Sánchez et al., 2009) and dementia in PD (Goris et al., 2007). 
Each of these disorders is associated with selective vulnerability of distinct brain regions within 
distributed functional brain networks (Zhou et al., 2012). Although there are suggestions that tau 
haplotype may contribute (Winder-Rhodes et al., 2015) to its association with these diseases, the 
mechanisms behind this susceptibility remain unclear. 
 
The misfolded and hyperphosphorylated tau protein may provide a pathogenic template for the 
propagation and spread of tau pathology. For example, in transgenic murine models it has been 
shown that tau can propagate via trans-synaptic spread (Ahmed et al., 2014; Liu et al., 2012) which 
promotes the transformation of normally expressed tau to pathogenic species (Clavaguera et al., 
2013). Here we propose that high levels of the intrinsic expression of tau in humans may enhance 
this templating process, thereby accelerating the pathogenesis of neurodegenerative disorders 
associated with tau and MAPT, by promoting the genesis and spread of the abnormal tau species. 
We predicted that brain regions with a higher expression of tau in healthy adulthood are more 
susceptible to a loss of function in the human diseases.  We predict this would be true in 
neurodegenerative syndromes associated with tau pathology such as PSP, as well as other diseases 
associated with genetic variation of MAPT such as PD. To test this hypothesis, we examined the 
regional expression of MAPT in a cohort of healthy subjects from the Allen Brain atlas. 
 
We contrasted the effect in MAPT with SNCA, the gene encoding alpha-synuclein which is 
associated with the pathology of PD but not PSP. Alpha-synuclein neuropathology in PD is 
localised to brainstem nuclei and the basal ganglia in early PD (Braak et al., 2003). In our 
population of PD subjects without dementia, we would therefore expect SNCA expression to have a 
limited effect on global network measures relevant to cognition. 
 
We used functional brain networks to look for an association between genetic and clinical 
descriptions, both in a healthy older cohort and in neurodegeneration (Hawrylycz et al., 2015; 
Meyer-Lindenberg and Weinberger, 2006; Richiardi et al., 2015). The analysis of the organization 
of large scale functional brain networks in health and neuropsychiatric disease exploits the 
synchronization of activity across neuronal populations in functionally and anatomically defined 
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networks (Bullmore and Sporns, 2009). Within these distributed networks, highly connected hub 
regions enhance network efficiency by connecting topologically remote regions (Power et al., 2013; 
Sporns et al., 2007). However, highly connected 'hub' regions may be particularly susceptible to 
neurodegeneration in Alzheimer's disease (Buckner et al., 2009) and other brain disorders (Crossley 
et al., 2014). 
 
We therefore started by examining the association between functional connection strength in health 
and gene expression, then went on to associate connection strength and gene expression with the 
proportional loss of connection strength in PSP and CBS. We focused on hub regions to explore the 
link between functional connection strength and cognition in PD and PSP. 
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2.1 Subjects 
146 subjects (60 age-matched controls, 30 PD without dementia MMSE >26/30 , 56 PSP) were 
recruited with written informed consent and approval from the local ethics committee. Of these, 16 
were excluded after functional magnetic resonance imaging (fMRI) image pre-processing revealed 
a focal lesion, significant white matter hyperintensities or motion dependent confounds on 
connectivity measures. In the remaining 128 participants (53 controls, 30 PD, 45 PSP) there were 
no group differences in age, gender, handedness or years of education; as expected, cognition was 
more impaired in PD and PSP groups using the MMSE (table 1). For motor function we report both 
the Unified Parkinson's Disease Rating Scale (UPDRS III) and for motor and non-motor symptoms 
in the PSP group, the PSP Rating Scale (PSPRS) (Golbe and Ohman-Strickland, 2007). Verbal 
fluency testing required subjects to generate words beginning with the letter 'p' (letter fluency) or 
animals (category fluency), each for one minute. These two scores were added together to produce a 
combined verbal fluency score. 
 
Microarray data from six post-mortem brain samples were obtained from the Allen Institute at 
http://human.brain-map.org (H0351.1009, H0351.1016, H0351.1015, H0351.2002, H0351.1012, 
H0351.2001), mean age 45.5 (range 24-57), all male, four right-handed, one left-handed, one 
ambidextrous. 
 
2.2 Image preprocessing 
Imaging was performed at the Wolfson Brain Imaging Centre, on a 3T Tim TRIO Siemens MRI 
scanner. Medication was not altered prior to scanning. Task-free echo-planar fMRI was acquired for 
a minimum of 145 volumes with subjects instructed to keep their eyes open (TR 2 secs, TE 30ms, 
flip angle 78, voxel size 3x3x3.75mm) and structural Magnetization-Prepared Rapid Acquisition 
with Gradient Echo (MPRAGE) scanning in the same session (TR 2.3 secs, TE 2.98, flip angle 9, 
voxel size 1mm isotropic). 
 
Pre-processing of structural scans involved optimised skull-stripping for atrophied brains (Acosta-
Cabronero et al., 2008) using affine transformation followed by non-linear warping using the FSL 
FNIRT tool to a group-specific template to ameliorate the challenge of warping atrophied brains 
before non-linear transformation to MNI standard space. Functional image preprocessing was 
tailored to minimise the effect of motion which can influence the correlation between distance and 
connectivity (Patel et al., 2014), and atrophy in neurodegenerative disease. The pipeline used a 
customised version of the fMRI signal processing toolbox (www.brainwavelet.org) and included 
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motion correction, regression of motion derivatives, white matter and CSF signal, local median 
despiking, high-pass band filtering of 0.01 Hz, and normalization to MNI standard space using 
parameters obtained from normalization of the structural image (performed in the described order). 
Quality control included (i) visual inspection at each preprocessing stage, (ii) measuring the 
influence of motion on correlation assessed using delta-BOLD and frame-wise displacement 
correlations, in a modified protocol from Power et al (2011) and Satterthwaite et al (2012). More 
specifically, subjects were excluded if there was greater than 5mm framewise displacement between 
any two TR intervals and if there was a significant correlation between motion and the change in 
BOLD signal measured by wavelet correlation before and after a ‘scrubbing’ procedure (delta-
BOLD). 
 
2.3 Network analysis 
A parcellation scheme divided grey matter of the MNI standard space template in to 500 non-
overlapping regions of equal size, using centroidal Voronoi tessellation (Du et al., 1999). After the 
random selection of 500 centroids, each region was constructed by assigning the remaining voxels 
to one of the different centroids. This regional allocation was performed by minimizing the 
Euclidean distance between each voxel and the set of centroids, thereby producing a three-
dimensional Voronoi tessellation. When ties occurred, these were broken using random allocation. 
Consequently, each region was composed of contiguous voxels with a mean size of 364.7 voxels (sd 
176.7). 
 
Of the 500 regions, 29 were insufficiently covered by the fMRI scans in some subjects, leaving 471 
brain regions for further analysis. Individual subjects' association matrices were constructed by 
extracting a time series from each parcel and performing a wavelet decomposition using a maximal 
overlap discrete wavelet transform and a Daubechie wavelet filter using the brainwaver package in 
R (http://cran.r-project.org/web/packages/brainwaver). The second band of four corresponding to a 
frequency range of 0.0675-0.125Hz was selected for further analysis (Achard et al., 2006). Graphs 
were constructed from association matrices without thresholding (negative weights retained) and 
based on the Fisher z-transforms of the correlation coefficients, and after wavelet decompositions of 
the fMRI timeseries. Network analysis was carried out in python 2.7 using the Maybrain package in 
python (https://github.com/rittman/maybrain) drawing on the networkx package (1.8.1, 
http://networkx.github.io). 
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diagnostic group. This was generated by calculating the mean connection strength of each brain 
region from all subjects within a diagnostic group. 
 
2.4 Hub definition and connectivity loss 
Verbal fluency scores were correlated with the mean connection strength of the most highly 
connected 'hub' regions. In the context of this paper, a hub was defined as brain region whose 
connection strength (the sum of all its connections) was above a threshold of 1.5 standard deviations 
of the mean connection strengths of all regions, based on the association matrix in control subjects 
(see supplementary data fig 1 demonstrating the location of hubs). 
 
The proportion of connectivity loss between the control group and PD or PSP group was calculated 
as the difference in connection strength between groups for each brain region normalised by the 
connectivity in the control group (Achard et al., 2012). Note that proportionate, rather than absolute, 
loss of hub connectivity is used, as hubs have by definition higher absolute connectivity while our 
hypotheses refer to the proportionate vulnerability of hubs to the progression of neuropathology.  
 
2.5 Microarray analysis 
Microarray data available from the Allen brain atlas was generated using an Agilent 8x60K array, 
custom-designed by Beckman Coulter Genomics. From this data, we identified four probes for the 
MAPT gene (A_23_P207699, A_24_P224488, A_32_P143793, CUST_449_PL1416408490) and 2 
probes for the SNCA gene (A_32_P109653 and A_23_29939). The specificity of each probe was 
reassessed using nucleotide BLAST (http://blast.ncbi.nlm.nih.gov/Blast.cgi) to identify genes and 
translated nucleotide sequences associated with each probe's sequence. Three of the four MAPT 
probes met our criteria: 100% homology with an area within the MAPT gene and associated 
transcripts and no other regions of homology, with very small E values to suggest good sensitivity. 
These three probes matched regions in the MAPT gene, A_23_P207699 and A_24_P224488 
homologous with the gene sequence to target complementary DNA and A_32_P143793 with the 
anti-sense sequence targeting complementary RNA. MAPT has 17 exons and is alternately spliced 
in to 6 isoforms, with two main groups differentiated by three or four repeats of the binding domain 
as a result of alternate splicing of exon 10. All probes recognized three and four repeat tau. The 
fourth probe (CUST_449_PL1416408490) showed only 88% homology with MAPT and 80% 
homology with a region on chromosome 18 and was discarded. Two probes in the Allen brain atlas 
data labelled as targeting SNCA (A_32_P109653 and A_23_29939) had 100% homology with 
regions in the SNCA gene with small E values. Both probes were homologous with complementary 
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(www.brain-map.org). 
 
2.6 Comparison between microarray and functional network data 
There were three challenges in identifying homologous regions between the genetic and imaging 
data: (i) only two Allen subjects have data from both hemispheres; (ii) regions in the Allen dataset 
are not evenly spaced; and (iii) the number and precise location of regions differ between Allen 
subjects. To address the challenge of missing data from the right hemisphere in 4 Allen subjects, the 
remaining two subjects were used to correlate microarray expression data between the hemispheres. 
We used the remaining two subjects with whole brain data to assess whether it was reasonable to 
use the single hemisphere data from the other 4 subjects to represent whole brain. For each brain 
region we calculated the Pearson correlation coefficient (Fisher's r-to-z transformed to enable 
statistical comparison) between the expression values of each hemisphere for 29131 probes 
associated with an identified gene. Data for the null hypothesis was generated by permuting inter-
hemispheric brain regions for 10,000 random region pairs. There was a significant difference 
between observed and permuted data for both subjects; subject A mean z=0.46, p<0.00001, subject 
B mean z=0.40, p<0.00001. We therefore analysed MAPT and SNCA data under the assumption of 
symmetry of gene expression. 
 
To address the second challenge of different spatial distributions between imaging and genetic data, 
each imaging region was associated with the nearest brain region from all Allen subjects combined. 
Finally, each Allen brain region's anatomical label was used to identify comparable regions across 
the six Allen subjects, in standard anatomical space. Each of the 471 imaging regions was then 
paired with an anatomically labelled region of the Allen atlas (see supplementary figure 2 
demonstrating regions of the Allen brain atlas included in the final analysis). For each region the 
gene expression value was calculated as the mean of all samples falling in to the appropriate brain 
regions from all 6 Allen subjects. 
 
2.7 Statistical analysis 
Statistical analysis was performed in R (v3.0.1 http://cran.r-project.org). Group-wise differences in 
node degree were tested using a t-test with p-values obtained using permutation testing (5000 
permutations) and corrected for multiple comparisons using the False Discovery Rate 
(FDR)(Benjamini and Yekutieli, 2001). Correlation between MAPT or SNCA expression and node 
degree used the Pearson correlation coefficient and p-values estimated from permutation testing. To 
assess the relationship between verbal fluency and the proportional loss of connection strength in 
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strength on verbal fluency. 
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We measured functional connectivity among 471 of 500 grey matter regions during task-free (or 
‘resting-state’) fMRI in 128 subjects: 30 people with PD, 45 people with PSP and 53 age- and sex-
matched healthy controls. Our principal measure of connectivity was the sum of connection weights 
to all other regions (hereafter connection strength), derived from the association matrix of z-
transformed wavelet correlations. To assess the relationship between functional connection strength 
and gene expression, we extracted the MAPT expression for each of three MAPT probes and two 
SNCA probes in 6 subjects from the Allen Brain Atlas. Figure 1 illustrates the inter-subject variation 
(ie standard deviation) in gene expression for each probe. Expression values were normalized for 
each probe within each subject: the mean expression value for each probe was zero, and the 
standard deviation was 1 for each probe (across all regions). Figures 2A and 2B illustrate the 
regional differences in the magnitude of MAPT and SNCA gene expression. 
 
There were positive correlations between MAPT expression and the connection strength in control 
subjects when values from all three MAPT probes were combined (r=0.29, p=<0.00001) and when 
examined separately (Fig 2C). Expression of SNCA did not correlate with connection strength when 
combining data across both probes (r=0.08, p>0.1), although the expression values of one probe 
correlated weakly with connection strength (A 32 P109653, r=0.12, p=0.036, see Fig 2). Next, we 
related these effects to PD and PSP. 
 
We assessed whether regions of high connection strength were susceptible to the effect of 
neurodegeneration in PD and PSP by measuring the proportional loss of connection strength across 
each of the 471 brain regions (Fig 3). It is expected that regions with more connections would lose 
more of these in absolute terms, but the hypothesis of selective vulnerability posits that  well 
connected regions lose a disproportionate number of connections, therefore our analysis examined 
the proportional loss of connection strength. Brain regions with greater connection strength in 
controls lost the largest proportion of connection strength in PD (r=0.61, p<0.00001 corrected) and 
PSP (r=0.44, p<0.00001). Brain regions that lost the greatest proportion of connection strength also 
had greater expression of MAPT  in PD (r=0.16, p=0.0014, corrected for multiple comparisons 
across two genes using a bonferroni correction) but not in PSP (r=0.06, p>0.1) and there were no 
significant associations with SNCA (PD: r=0.02, p>0.1, PSP: r=-0.08, p>0.1). 
 
Finally we examined the relevance of connectivity changes to cognitive performance. Although PSP 
and PD have distinct clinical phenotypes, both diseases are associated with early impairment of 
executive function (Williams-Gray et al., 2007) which can be indexed by verbal fluency (Burrell et 
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al., 2014). We identified the most highly connected 'hub' brain regions (as above) in control subjects 
and used the mean connection strength across hubs, applying analysis of covariance to account for 
the difference in distribution of verbal fluency scores of each group (Fig 4). The mean verbal 
fluency scores were: controls 40.3 (standard deviation 10.4), PD 34.3 (7.3), PSP 14.1 (8.6). The 
connection strength of hub regions positively covaried with verbal fluency in both patient groups, ie 
greater connection strength was associated with greater verbal fluency (F=6.1, df=1, p=0.02). There 
was no interaction between this covariance and diagnosis (F=1.3, df=1, p>0.1), although post hoc 
correlations demonstrated that verbal fluency declined with the loss of hub connectivity in PD (PD: 
r=0.52, df=21, p=0.01; PSP: r=0.21, df=38, p>0.1). Motor scores (UPDRS III) did not correlate 
with a loss of connection strength (F=0.02, df=1, p>0.1). 
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We have shown that the regional expression of the MAPT gene in health is associated with regions 
of high connectivity which predict the functionally relevant loss of connectivity in PSP, a 
neurodegenerative diseases associated strongly with progressive misfolding and aggregation of the 
protein tau. Similar changes were observed in PD, which is more associated with alpha-synculein 
pathology but for which the risk of disease and accompanying dementia are associated with tau 
haplotypes. 
 
Accumulating evidence points to the susceptibility of highly connected hub regions to change in a 
wide range of neurological and neuropsychiatric disease (Crossley et al., 2014). This evidence 
includes neurodegenerative syndromes such as Alzheimer's disease where the hub selectivity of 
connection strength has been linked to greater metabolic demands (Buckner et al., 2009). Highly 
connected brain regions can also be considered 'expensive' to maintain because they have large 
numbers of connections which may make them vulnerable to disease processes because of their 
high metabolism (Achard and Bullmore, 2007), or through 'hub overload' of information that would 
usually be managed by other disease-affected brain regions (Stam, 2014). Furthermore, greater 
connectivity may increase the probability of transferring and receiving harmful protein species 
(Clavaguera et al., 2013; Liu et al., 2012). 
 
Our findings extend these network-based hypotheses by linking global network properties directly 
to the underlying expression of native tau in humans. Global network properties have been found to 
mirror patterns in gene expression(Fulcher and Fornito, 2016; Rubinov et al., 2015), and more 
specifically the association between MAPT expression and connection strength reflects the 
importance of the tau protein in maintaining axonal integrity by stabilising microtubules (Lindwall 
and Cole, 1984). In humans, previous imaging studies have linked single gene variants with patterns 
of change in brain imaging (Filippini et al., 2009; Mata et al., 2014; Whitwell et al., 2011). We go 
further to suggest that the regional variation in the MAPT gene expression in health can contribute 
to the selective vulnerability of a densely connected region: specifically, more highly connected 
regions may be intrinsically susceptible to neurodegeneration mediated by tau dysfunction. 
 
The correlation between MAPT expression and the proportional loss of connection strength was 
greater in PD than for PSP. The variability between these two diseases suggests that multiple genes 
and disease processes are involved in the loss of functional connections between brain regions. Our 
approach was to test an hypothesis based on a known gene associated with cognitive changes in the 
two disorders of interest. A more exploratory approach investigating all the available microarray 
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genes but would require careful control of type I statistical error. Our study was not powered to 
conduct such a study. 
 
In contrast to MAPT we did not find a strong association between SNCA expression and functional 
connectivity in health, or loss of connectivity in disease. There was a weak association between one 
SNCA probe and connectivity in health, but this was not matched by changes in disease. This is 
despite the association of PD with alpha-synuclein pathology. Lewy bodies containing alpha-
synuclein are the hallmark of Parkinson's disease pathology (Spillantini et al., 1997) and there is 
now emerging evidence that alpha-synuclein could spread across neural networks and cause 
aggregation and cell loss through a prion-like process (Hansen and Li, 2012; Li et al., 2008). There 
is a correlation between cortical deposition of alpha-synuclein and dementia (Hurtig et al., 2000), 
however our cohort of PD patients specifically excluded patients with dementia. We suggest that the 
role of alpha-synuclein is PD without dementia is not relevant to the more cortically-derived 
network measures we employed to examine large scale network functional connectivity. 
 
We have examined functional connection strength across the whole brain, but the brain's functional 
network can be examined as a series of macroscopic brain networks, some of which have been 
associated with individual neurodegenerative diseases (Seeley et al., 2009). In the context of our 
results, the recent finding that gene expression may predict connectivity patterns (Hawrylycz et al., 
2015; Richiardi et al., 2015) raises the possibility that gene expression patterns and their products 
may contribute to the susceptibility of specific brain networks to specific neurodegenerative 
pathologies. 
 
We identified a clinical effect of destabilising highly connected hub regions by demonstrating that 
verbal fluency declines with a loss of connection strength. Verbal fluency is a key component of 
early cognitive impairment in both PD and PSP (Rittman et al., 2013), and arises from the 
orchestrated function of multiple brain regions (Henry and Crawford, 2004). Therefore, a loss of the 
coordinating function of highly connected brain regions is expected to have a detrimental effect on 
verbal fluency. 
 
A strength of our study is the hypothesis-driven selection of genes relevant to PSP and PD. This 
contrasts with an exploratory data-driven approach (Hawrylycz et al., 2015; Richiardi et al., 2015) 
which may reduce the statistical power to detect relevant effects of individual genes. However, we 
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recognize that there are likely to be other genes that play a role in the pathology underlying PD and 
PSP whose differential expression may contribute to pathogenesis. 
 
There are a number of limitations to this study. Firstly, the gene expression data and imaging data 
were necessarily obtained from different populations. Although our hypothesis was based on 
evidence for the involvement of tau in both PD and PSP, we recognise that gene-connectivity 
relationships may not exist in all disorders where there is a change in connectivity and therefore a 
more direct imaging-pathology correlation in a single population would be the optimum approach. 
Secondly, the Allen database from which the gene expression data was derived includes only six 
subjects raising the possibility that inter-individual variance may account for our findings. However, 
the main statistical comparison was among the 471 defined brain regions rather than the 6 
individuals, and in 5 of the 6 subjects we found similarly significant within-subject correlations 
between MAPT expression and connection strength demonstrating that our results were not 
dependent on one or two subjects. Finally, our results may not be specific for PD and PSP. It will be 
important to replicate our findings in independent cohorts and in other tau-associated 
neurodegenerative disorders such as Alzheimer's disease and FTD. 
 
In conclusion, our results link molecular and imaging data in support of hypotheses of network 
vulnerability to neurodegenerative pathologies. We propose that brain regions expressing greater 
levels of the MAPT gene are more susceptible to neurodegeneration associated with the MAPT 
haplotype or mediated by tau pathology. 
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Figure 1. This figure demonstrates the variability in microarray expression data between the six 
Allen brain atlas subjects; the size of each sphere is scaled by the standard deviation of gene 
expression in the region. This was measured by normalising the expression values within each 
subject to a mean of 0 and standard deviation of 1, then assessing the inter-individual standard 
deviation at each brain region. These results confirm an acceptable variability between subjects, 
with less variability in cortical compared to subcortical regions. There were no regions with an 
unacceptably high variability between subjects. 
 
Figure 2. The relationship between functional connection strength in control subjects and 
expression of MAPT and SNCA genes. The connection strength was measured in control subjects as 
the mean r-to-z transformed wavelet cross-correlation between the task-free fMRI activity of a 
region and all other regions. Genetic microarray expression data was obtained from the Allen brain 
database by matching regions in the Allen brain to brain regions imaged, and aggregating 
expression values for gene probes across subjects and normalised within each subject. Panel A 
shows the distribution of expression values for MAPT and SNCA aggregated across microarray 
probes using an arbitrary scaling. In both genes the cortex has greater gene expression than the 
cerebellum and subcortical regions. In MAPT the posterior cortical regions including the precuneus 
and posterior temporal lobe regions demonstrate greatest gene expression. Panel B shows glass 
brain projections of expression values for each probe individually. Panel C shows significant 
correlations between the regional distribution of functional connection strength and the expression 
of MAPT, a correlation that remained when values from the three probes were aggregated (r=0.29, 
p<0.00001 corrected). One of the SNCA probes weakly correlated with connection strength, 
although this did not survive when combining both SNCA probes (r=0.08, p>0.1 corrected). 
 
Figure 3. The proportionate (not absolute) loss of connectivity strength in PSP and PD subjects 
across 471 regions. Functional connection strength in health predicts the proportional loss of 
connection strength in both PSP and PD, supporting the hypothesis that more connected regions 
(including hubs) are particularly susceptible to neurodegeneration. Panel A shows the proportional 
loss of connection strength in disease by region. Panel B shows the significant relationships 
between the connection strength in control subjects and proportional change of connection strength 
in disease groups. 
 
Figure 4. The connection strength in highly connected hub brain regions correlates with verbal 
fluency in PD and PSP (F=6.1, df=1, p=0.02; post-hoc t-tests PD: r=0.52, df=21, p=0.01; PSP: 
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r=0.21, df=38, p>0.1), but there was no correlation between hub connection strength and motor 
function measured using UPDRS (F=0.02, df=1, p>0.1; post-hoc t-tests, PD: r=-0.035, p=0.9; PSP 
r=0.038, p=0.8). 
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Table 1: Demographics for all patient groups. The mean and range are shown where appropriate. 
Statistical comparison was made using analysis of variance for age and MMSE, t-test for UPDRS 
and chi-square test for handedness and gender. UPDRS = Unified Parkinson's Disease Rating Scale, 
PSPRS = Progressive Supranuclear Palsy Rating Scale, MMSE = Mini-Mental State Examination, 
ns = non-significant p>0.1. 
  
  Control PD PSP  p-value 
Mean age (range) 66.7 (40.6-84.4) 66.8 (46.9-77.0) 70.8 (58.3-92.5) ns 
Handedness (R/L)  52/1 29/1 40/5 ns 
Gender (M:F) 30/23 15/15 23/22 ns 
UPDRS III (range) - 20.8 (7-38) 36.7 (8-69) <0.00001 
PSPRS  - - 38.3 (13-79) - 
MMSE (range) 29 (26-30) 28.4 (23-30) 24.5 (7-30) <0.00001 
 
M
AN
US
CR
IP
T
 
AC
CE
PT
ED
ACCEPTED MANUSCRIPTDeclaration of interest 
Conflicts of interest: none. 
M
AN
US
CR
IP
T
 
AC
CE
PT
ED
ACCEPTED MANUSCRIPT
 
M
AN
US
CR
IP
T
 
AC
CE
PT
ED
ACCEPTED MANUSCRIPT
 
M
AN
US
CR
IP
T
 
AC
CE
PT
ED
ACCEPTED MANUSCRIPT
 
M
AN
US
CR
IP
T
 
AC
CE
PT
ED
ACCEPTED MANUSCRIPT
 
M
AN
US
CR
IP
T
 
AC
CE
PT
ED
ACCEPTED MANUSCRIPTHighlights 
• Highly connected brain regions have greater expression of the tau gene MAPT 
• Highly connected brain regions are susceptible in two disorders associated with tau 
• The loss of connectivity in these disorders correlates with executive dysfunction 
• Greater MAPT expression may confer susceptibility to tau associated neuropathology 
